Shareholders Turn Down Tender Offer to Take BioCanCell Private Post author:Sam Post published:December 27, 2017 Post category:BioPharma Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace You Might Also Like Merck's Cyber Attack Could Cost Insurers $275M October 19, 2017 Celgene Co-Founder Bags $23M for Johns Hopkins Spinout NexImmune January 1, 2018 3 Overlooked Biopharmas Insiders are Snapping Up January 29, 2018
